Pharmaceutical litigation over Xarelto injuries continues to grow

Ohio patients who struggle with blood clots may do well to familiarize themselves with recent federal lawsuits regarding a drug known as Xarelto. The prescription medication is a blood thinner intended to treat clotting issues. However, as alleged by a number of pharmaceutical litigation cases against the manufacturers, the life-threatening side effects may not be worth the risk.

In 2011, the medication was approved by the Food and Drug Administration for patients suffering from atrial fibrillation and from clotting issues. Blood clots can lead to strokes, pulmonary embolisms, heart attacks and other severe health issues. Unfortunately, in combating these issues, the blood thinner Xarelto allegedly causes serious internal bleeding in some patients, leading to severe injury or even death.

One of the most recent cases to go to trial involves a 69-year-old woman in another state who is suing a subsidiary of Johnson & Johnson: Bayer and Janssen Pharmaceuticals, the manufacturer of the drug. She was prescribed Xarelto early in 2015 for treatment of a blood clot in her leg. The suit complains that, after taking the medication, the plaintiff suffered acute blood loss anemia due to severe gastrointestinal bleeding.

This is far from the first time legal claims and concerns have been raised over the safety of this drug. Complaints have arisen that outside the U.S., physicians were informed of the importance of patient monitoring via blood tests to prevent serious bleeding, but that the drug manufacturers failed to tell American doctors, an action which has allegedly adversely affected thousands of patients. Anyone in Ohio who has suffered drug injuries from this or any other dangerous medications may benefit from exploring their legal rights with an attorney experienced in pharmaceutical litigation.

Source: pennrecord.com, "Third bellwether trial for Xarelto now underway in Mississippi federal court", Nicholas Malfitano, Aug. 10, 2017

No Comments

Leave a comment
Comment Information

Free Case Evaluation:

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

FindLaw Network Newsweek Showcase - Leaders in Asbestos Law - 2012